These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5300804)

  • 1. [On simplex formation with heparin of the kallikrein inhibitor from bovine organs].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1502-4. PubMed ID: 5300804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation and properties of active derivatives of the trypsin-kallikrein inhibitor from bovine organs].
    Fritz H; Schult H; Meister R; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 Dec; 350(12):1531-40. PubMed ID: 4243596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Identity of the polyvalent protease inhibitor from sheep lung with the trypsin-kallikrein inhibitor from bovine organs].
    Fritz H; Greif B; Schramm W; Hochstrasser K; Werle E
    Hoppe Seylers Z Physiol Chem; 1970 Feb; 351(2):139-44. PubMed ID: 5309228
    [No Abstract]   [Full Text] [Related]  

  • 4. [On coagulation inhibiting effect of proteinase inhibitors from animal organs].
    Gülzow M; Schulz K
    Z Gesamte Inn Med; 1967 Nov; 22(21):641-7. PubMed ID: 5302275
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the kinetics of the reaction between kallikrein inactivator and trypsin].
    Pütter J
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1197-206. PubMed ID: 5301336
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbohydrate-containing derivatives of the trypsin-kallikrein inhibitor aprotinin from bovine organs. I. Modification with lactose, characterization and behaviour of the preparation in vivo.
    Larionova NI; Mityushina GV; Kazanskaya NF; Blidchenko YA; Berezin IV
    Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):791-7. PubMed ID: 6207095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Formation of the heparin-calcium complex].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1982; 28(5):112-5. PubMed ID: 7179827
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Precipitation by chloroform as a method for studying DNA denaturation and degradation].
    Lystsov VN; Moshkovskiĭ IuSh; Tubasova IA
    Biokhimiia; 1967; 32(6):1195-200. PubMed ID: 5592919
    [No Abstract]   [Full Text] [Related]  

  • 10. The disulfide linkages in kallikrein inactivator of bovine lung.
    Anderer FA; Hörnle S
    J Biol Chem; 1966 Apr; 241(7):1568-72. PubMed ID: 5296424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of nonenzymatic fibrinolysis].
    Litvinov VI; Slabnov IuD; Zubairov DM
    Vopr Med Khim; 1981; 27(4):478-81. PubMed ID: 6457444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.
    Fritz H; Wunderer G
    Arzneimittelforschung; 1983; 33(4):479-94. PubMed ID: 6191764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
    Tanaka KA; Szlam F; Katori N; Vega JD; Levy JH
    Thromb Res; 2004; 113(5):333-9. PubMed ID: 15183046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of aprotinin from porcine lungs.
    de Cássia Dias S; Sakauchi D; Abreu PA; de Lima Netto S; Iourtov D; Raw I; Kubrusly FS
    Biotechnol Lett; 2008 May; 30(5):807-12. PubMed ID: 18071638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical studies on kallikrein inactivator from bovine lung and parotid gland.
    Anderer FA; Hörnle S
    Ann N Y Acad Sci; 1968 Jun; 146(2):381-5. PubMed ID: 5305808
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI.
    Nielsen VG
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):168-72. PubMed ID: 16430537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On protease inhibitors, VI. On the identity of the protease inhibitor from rat liver with the trypsin-kallikren-inhibitor (Trasylol].
    Fritz H; Hutzel M; Werle E
    Hoppe Seylers Z Physiol Chem; 1967 Jul; 348(7):950. PubMed ID: 5301897
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
    Oddone R; Barra D; Amiconi G; Ascenzi P; Tarricone C; Bolognesi M; Bortolotti F; Menegatti E
    J Mol Recognit; 1994 Mar; 7(1):39-46. PubMed ID: 7527234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible stages of intravascular coagulation and their effect on kidney function and urokinase excretion].
    Theiss W; Graeff H; Bleyl U; Immich H; Kuhn W
    Thromb Diath Haemorrh; 1970 May; 23(2):369-85. PubMed ID: 5310552
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of the enzymatic degradation of deoxyribonucleoproteins in vitro upon their interaction with heparin].
    Ermolaeva NV; Skalka M; Matyashova I
    Biokhimiia; 1967; 32(6):1278-84. PubMed ID: 5592923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.